22.02.2026, 1009 Zeichen

Agrana: Due to the continuing difficult market environment in the Sugar segment, a non-cash impairment loss is expected to be recognised in the Agrana Group as part of the indication-based impairment test of assets as of the balance sheet date. The impairment is forecast to impact the assets of the ACS – Sugar segment to an extent of between € 45 and € 55 million. The final amount of the impairment loss will be determined in the course of preparing AGRANA's consolidated financial statements for the 2025|26 financial year (balance sheet date: 28 February 2026). The forecast non-cash impairment will be reported under exceptional items and thus have a negative impact on the previous guidance for EBIT^1. At Group level, management had expected EBIT to increase significantly to a range of around € 45 million to € 60 million for the 2025|26 financial year prior to the impairment.
Agrana: weekly performance: -1.71%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (17/02/2026)

Christian Drastil: Wiener Börse Plausch

Zertifikate Party Österreich: Frank Weingarts, ZFA-Vorstandschef und -Evergreen: Thema SRI (noch 10 Tage bis zum 20. Zertifikate Award 2026)

Bildnachweis

Aktien auf dem Radar:Austriacard Holdings AG, Mayr-Melnhof, AT&S, Amag, Zumtobel, Agrana, Semperit, Flughafen Wien, Reploid Group AG, Lenzing, FACC, Frauenthal, RBI, SW Umwelttechnik, VIG, voestalpine, Polytec Group, BTV AG, BKS Bank Stamm, EuroTeleSites AG, CPI Europe AG, Österreichische Post, Telekom Austria, SAP, Rheinmetall, IBM, salesforce.com, Fresenius Medical Care, Fresenius, Deutsche Bank, Münchener Rück.

---